Diabetes drug gets second chance as depression fighter

NCT ID NCT07239011

Recruiting now Disease control Sponsor: Tanta University Source: ClinicalTrials.gov ↗

Summary

This study is testing whether dapagliflozin, a medication normally used for diabetes, can help control depression symptoms. Researchers are enrolling 60 adults with depression who haven't responded well to standard treatments. The trial will measure changes in depression symptoms and quality of life over time.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DEPRESSION are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Locations

Mostafa Bahaa
RECRUITING

Damietta, New Damietta, 34518, Egypt

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

DEPRESSION